Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.05%197.481.2%$507.52m
GILDGilead Sciences, Inc.
1.50%73.590.9%$447.06m
BIIBBiogen Inc.
1.12%330.941.3%$368.60m
CELGCelgene Corporation
2.32%82.581.2%$330.45m
ILMNIllumina, Inc.
4.63%321.693.5%$290.45m
REGNRegeneron Pharmaceuticals, Inc.
3.36%384.162.6%$223.94m
ALXNAlexion Pharmaceuticals, Inc.
0.00%121.942.0%$208.74m
VRTXVertex Pharmaceuticals Incorporated
3.22%181.321.9%$203.48m
SRPTSarepta Therapeutics, Inc.
6.96%130.5016.4%$166.42m
AAgilent Technologies, Inc.
2.03%66.211.5%$154.48m
BMRNBioMarin Pharmaceutical Inc.
2.27%99.514.4%$128.35m
VKTXViking Therapeutics, Inc.
4.25%14.460.9%$108.76m
LGNDLigand Pharmaceuticals Incorporated
-1.50%202.5923.3%$108.14m
NKTRNektar Therapeutics
2.11%48.915.6%$105.47m
EXASExact Sciences Corporation
1.22%67.2225.3%$98.13m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.